# Bilibili Inc.: financial statements, quarterly

BILI · Nasdaq · CIK 1723690 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bili.md) · [Financials](/companies/bili/financials.md) · [Filings](/companies/bili/filings.md) · [Insiders](/companies/bili/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bili/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [111](/filings/0001104659-19-021128.md) | [508](/filings/0001193125-20-088657.md) | [761](/filings/0001193125-21-071497.md) | [734](/filings/0001193125-22-116261.md) | [1,181](/filings/0001193125-22-116261.md) | [1,475](/filings/0001193125-23-119748.md) | [1,013](/filings/0001193125-24-078124.md) | [1,404](/filings/0001193125-25-061847.md) | [1,742](/filings/0001193125-26-157842.md) |
| Current assets | $m | not reported | [953](/filings/0001104659-19-021128.md) | [1,483](/filings/0001193125-20-088657.md) | [2,412](/filings/0001193125-21-071497.md) | [5,719](/filings/0001193125-22-116261.md) | [3,545](/filings/0001193125-23-119748.md) | [2,638](/filings/0001193125-24-078124.md) | [2,707](/filings/0001193125-25-061847.md) | [3,940](/filings/0001193125-26-157842.md) |
| Total assets | $m | not reported | [1,526](/filings/0001104659-19-021128.md) | [2,229](/filings/0001193125-20-088657.md) | [3,658](/filings/0001193125-21-071497.md) | [8,168](/filings/0001193125-22-116261.md) | [6,065](/filings/0001193125-23-119748.md) | [4,670](/filings/0001193125-24-078124.md) | [4,480](/filings/0001193125-25-061847.md) | [5,887](/filings/0001193125-26-157842.md) |
| Current liabilities | $m | not reported | [480](/filings/0001104659-19-021128.md) | [614](/filings/0001193125-20-088657.md) | [1,133](/filings/0001193125-21-071497.md) | [1,894](/filings/0001193125-22-116261.md) | [2,478](/filings/0001193125-23-119748.md) | [2,550](/filings/0001193125-24-078124.md) | [2,022](/filings/0001193125-25-061847.md) | [2,907](/filings/0001193125-26-157842.md) |
| Total liabilities | $m | not reported | [480](/filings/0001104659-19-021128.md) | [1,132](/filings/0001193125-20-088657.md) | [2,465](/filings/0001193125-21-071497.md) | [4,761](/filings/0001193125-22-116261.md) | [3,855](/filings/0001193125-23-119748.md) | [2,642](/filings/0001193125-24-078124.md) | [2,547](/filings/0001193125-25-061847.md) | [3,663](/filings/0001193125-26-157842.md) |
| Long-term debt | $m | not reported | not reported | [490](/filings/0001193125-20-088657.md) | [1,278](/filings/0001193125-21-071497.md) | [2,791](/filings/0001193125-22-116261.md) | [1,259](/filings/0001193125-23-119748.md) | [0.1](/filings/0001193125-24-078124.md) | [447](/filings/0001193125-25-061847.md) | [683](/filings/0001193125-26-157842.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [960](/filings/0001193125-23-119748.md) | [1,050](/filings/0001193125-24-078124.md) | [0.7](/filings/0001193125-26-157842.md) | [3,262](/filings/0001193125-26-157842.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [15.3](/filings/0001193125-21-071497.md) | [193](/filings/0001193125-22-116261.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | not reported | [1,011](/filings/0001104659-19-021128.md) | [1,013](/filings/0001193125-20-088657.md) | [1,165](/filings/0001193125-21-071497.md) | [3,406](/filings/0001193125-22-116261.md) | [2,209](/filings/0001193125-23-119748.md) | [2,027](/filings/0001193125-24-078124.md) | [1,933](/filings/0001193125-25-061847.md) | [2,227](/filings/0001193125-26-157842.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.